RT Journal Article
SR Electronic
T1 The toll of COVID-19 on African children: A descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.02.21259857
DO 10.1101/2021.07.02.21259857
A1 Velásquez, Sabina Rodriguez
A1 Jacques, Léa
A1 Dalal, Jyoti
A1 Sestito, Paolo
A1 Habibi, Zahra
A1 Venkatasubramanian, Akarsh
A1 Nguimbis, Benedict
A1 Mesa, Sara Botero
A1 Chimbetete, Cleophas
A1 Keiser, Olivia
A1 Impouma, Benido
A1 Mboussou, Franck
A1 William, George Sie
A1 Ngoy, Nsenga
A1 Talisuna, Ambrose
A1 Gueye, Abdou Salam
A1 Hofer, Cristina Barroso
A1 Cabore, Joseph Waogodo
YR 2021
UL http://medrxiv.org/content/early/2021/07/06/2021.07.02.21259857.abstract
AB Introduction Since the beginning of the COVID-19 pandemic, very little data on the epidemiological characteristics among the pediatric population in Africa has been published. This paper examines the age and sex distribution of the morbidity and mortality rate in children with COVID-19 and compares it to the adult population within 15 Sub-Saharan African countries.Methods A merge line listing dataset using a reverse engineering model shared by countries within the Regional Office for Africa was analyzed. Patients diagnosed within 1 March 2020 and 1 September 2020 with confirmed positive RT-PCR test for SARS-CoV-2 were analyzed. Children’s data were stratified into three age groups: 0-4 years, 5-11 years, and 12-17 years, while adults were combined. The cumulative incidence of cases including its medians and 95% confidence intervals were calculated.Results 9% of the total confirmed cases and 2.4% of the reported deaths were pediatric cases. The 12-17 age group in all 15 countries showed the highest cumulative incidence proportion in children. COVID-19 cases in males and females under the age of 18 were evenly distributed. Among adults, a higher case incidence per 100,000 people was observed compared to children.Conclusion The cases and deaths within the children’s population was smaller than the adult population. These differences can reflect biases in COVID-19 testing protocols and reporting implemented by countries, highlighting the need for more extensive investigation and focus on the effects of COVID-19 in children.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data were collected for surveillance purposes under IHR, and no ethical approval was needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author. Some of the data are publicly available through situation reports produced by Ministries of Health and WHO/AFRO on their respective websites.